Combination therapy for the treatment of cancer.

摘要

The present invention relates to methods for treatment or prevention of neoplasia disorders using protein tyrosine kinase inhibitors of the formula I: wherein R¹, R², R³, R⁴, R⁵, R⁶, and R⁷ are defined herein, in combination with cyclooxygenase inhibitors, in particular cyclooxygenase-2 selective inhibitors.